- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Veru Inc (VERU)
Assess today's live Veru Inc (VERU) share price, performance and insights using our live NASDAQ: VERU stock exchange data.
Analyse the historical data and Veru Inc share price performance charts on this page. Our technical summary section provides analysis on Veru share price buy/sell indicators using real-time data (or discuss the Veru (VERU) stock price today with other investors in the Veru NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ VERU share price (ISIN: US92536C1036) to enhance your trading decisions with our free investment tools and resources.
What Is the Veru Inc Share Price Today?
The Veru share price today is 0.505.
What Is the Stock Symbol for Veru Inc
The stock symbol (or 'ticker') for Veru Inc is "VERU."
What Stock Exchange Does Veru Inc Trade On?
Veru Inc is listed and trades on the NASDAQ stock exchange.
Is Veru Inc a Good Stock to Buy?
Determining whether Veru Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Veru Inc share price performance charts on this page. Our technical summary section provides analysis on Veru share price buy/sell indicators using real-time data (or discuss the Veru (VERU) stock price today with other investors in the Veru NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ VERU share price (ISIN: US92536C1036) to enhance your trading decisions with our free investment tools and resources.
What Is the Veru Inc Share Price Today?
The Veru share price today is 0.505.
What Is the Stock Symbol for Veru Inc
The stock symbol (or 'ticker') for Veru Inc is "VERU."
What Stock Exchange Does Veru Inc Trade On?
Veru Inc is listed and trades on the NASDAQ stock exchange.
Is Veru Inc a Good Stock to Buy?
Determining whether Veru Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
0.505
-0.017(-3.26%)
Closed
After Hours
0.517+0.012(+2.376%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.502
0.528
52 wk Range
0.450
1.920
VERU Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5020.528
52 wk Range
0.4501.920
Veru Inc is currently considered to be UndervaluedExplore our list of undervalued stocks for hidden opportunities
Veru Inc is not on our AI-picked strategiesExplore current and previous stocks selected by AI
Try Warren AI research assistant for instant insights on Veru IncFrom metrics, to news, charts, and even a SWOT analysis - you can ask anything!
What you should know about Veru IncHolds more cash than debt on its balance sheetHigh shareholder yield
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VERU Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Price Target
3.250
Upside
+543.56%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Veru Company Profile
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company’s development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Veru Inc Earnings Call Summary for Q1/2025
- Q1 FY2025: Net loss of $0.06/share, beating -$0.08 forecast; revenue $3.2M vs $3M expected; stock down 6.24% pre-market
- Strategic shift: Sold FC2 female condom business for $18M, focusing on drug development with Enobasarm and Cebizobulin
- Financial position: $26.6M cash on hand; aims to fund operations through year-end; healthy current ratio of 2.97x
- Outlook: Projecting losses for upcoming quarters; revenue forecast $3M annually for FY2025 and FY2026
- R&D focus: Increased investment to $5.7M; CEO highlights potential of drug candidates for weight reduction and inflammation
Last Updated: 13/02/2025, 15:00
Read Full TranscriptCompare VERU to Peers and Sector
Metrics to compare | VERU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVERUPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.3x | −0.9x | −0.5x | |
PEG Ratio | −0.04 | 0.01 | 0.00 | |
Price/Book | 2.8x | 0.5x | 2.6x | |
Price / LTM Sales | 4.4x | 0.4x | 3.0x | |
Upside (Analyst Target) | - | 29.6% | 54.1% | |
Fair Value Upside | Unlock | 18.5% | 9.4% | Unlock |
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.250
(+543.56% Upside)
Earnings
Latest Release
Feb 13, 2025
EPS / Forecast
-0.06 / -0.08
Revenue / Forecast
3.20M / 3.00M
People Also Watch
FAQ
What Is the Veru (VERU) Stock Price Today?
The Veru stock price today is 0.505
What Stock Exchange Does Veru Trade On?
Veru is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Veru?
The stock symbol for Veru is "VERU."
What Is the Veru Market Cap?
As of today, Veru market cap is 73.89M.
What is Veru Earnings Per Share?
The Veru EPS is -0.263.
What Is the Next Veru Earnings Date?
Veru will release its next earnings report on 06 May 2025.
From a Technical Analysis Perspective, Is VERU a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.